Mail

Canada markets close in 3 hours 37 minutes

S&P/TSX
22,427.68
-40.48(-0.18%)
S&P 500
5,320.38
-1.03(-0.02%)
DOW
39,833.00
-39.99(-0.10%)
CAD/USD
0.7319
-0.0016(-0.22%)
CRUDE OIL
77.82
-0.84(-1.07%)
Bitcoin CAD
96,332.38
+541.35(+0.57%)

MARKETS LIVE BLOG

STOCKS SLIP AS WAIT FOR NVIDIA EARNINGS NEARS END

Target issues weak forecast as shoppers pull back on spending; shares tumble

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed Price. Currency in HKD

Add to watchlist

13.160

-0.020

(-0.15%)

At close: 04:08PM HKT

Currency in HKD

Valuation Measures⁴

Market Cap (intraday)	54.80B
Enterprise Value	47.46B
Trailing P/E	15.58
Forward P/E	11.78
PEG Ratio (5 yr expected)	0.79
Price/Sales (ttm)	3.06
Price/Book (mrq)	1.24
Enterprise Value/Revenue	2.54
Enterprise Value/EBITDA	7.85

Trading Information

Stock Price History

Beta (5Y Monthly)	0.63
52-Week Change ³	-70.28%
S&P500 52-Week Change ³	29.31%
52 Week High ³	52.450
52 Week Low ³	12.420
50-Day Moving Average ³	14.322
200-Day Moving Average ³	30.736

Share Statistics

Avg Vol (3 month) ³	64.32M
Avg Vol (10 day) ³	99.15M
Shares Outstanding ⁵	4.16B
Implied Shares Outstanding ⁶	4.31B
Float ⁸	3.62B
% Held by Insiders ¹	14.18%
% Held by Institutions ¹	40.83%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	3:1
Last Split Date ³	Nov 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Dec 31, 2023

Profitability

Profit Margin	19.96%
Operating Margin (ttm)	19.09%

Management Effectiveness

Return on Assets (ttm)	4.63%
Return on Equity (ttm)	8.90%

Income Statement

Revenue (ttm)	17.03B
Revenue Per Share (ttm)	4.09
Quarterly Revenue Growth (yoy)	6.00%
Gross Profit (ttm)	N/A
EBITDA	4.93B
Net Income Avi to Common (ttm)	3.4B
Diluted EPS (ttm)	0.850
Quarterly Earnings Growth (yoy)	-39.90%

Balance Sheet

Total Cash (mrq)	11.24B
Total Cash Per Share (mrq)	2.66
Total Debt (mrq)	4.56B
Total Debt/Equity (mrq)	10.36%
Current Ratio (mrq)	2.78
Book Value Per Share (mrq)	9.55

Cash Flow Statement

Operating Cash Flow (ttm)	4.67B
Levered Free Cash Flow (ttm)	-320.31M